Description
This variant is denoted APC c.44C>T at the cDNA level, p.Ala15Val (A15V) at the protein level, and results in the change of an Alanine to a Valine (GCA>GTA). This variant has not, to our knowledge, been published in the literature as pathogenic or benign. APC Ala15Val was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. Since Alanine and Valine share similar properties, this is considered a conservative amino acid substitution. APC Ala15Val occurs at a position that is conserved across species and is located within the oligomerization domain (Azzopardi 2008). Protein-based in silico analyses are inconsistent regarding the effect this variant may have on protein structure and function. Multiple splicing models predict gain of a cryptic splice donor site upstream of the natural site; however these models predict no change to the natural splice donor site. In the absence of RNA or functional studies, the actual effect of this variant is unknown. Based on currently available information, it is unclear whether APC Ala15Val is pathogenic or benign. We consider it to be a variant of uncertain significance.
# | Sample | Method | Observation |
---|
Origin | Affected | Number tested | Tissue | Purpose | Method | Individuals | Allele frequency | Families | Co-occurrences |
---|
1 | germline | yes | not provided | not provided | not provided | | not provided | not provided | not provided | not provided |